Sign Up to like & get
recommendations!
0
Published in 2017 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2017.05.355
Abstract: PURPOSE A fixed-dose combination (FDC) pill of amlodipine (relatively old calcium channel blocker as dihydropyridine) and olmesartan (relatively new angiotensin II receptor blocker) is used for hypertension that is not adequately controlled with a single-formulation…
read more here.
Keywords:
bioequivalence;
dose combination;
product;
olmesartan medoxomil ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug Delivery"
DOI: 10.1080/10717544.2022.2086939
Abstract: Abstract Olmesartan medoxomil (OM) is an angiotensin receptor blocker. This study aimed to investigate the effects of OM self-microemulsifying drug delivery system (OMS) in trinitrobenzene sulfonic acid (TNBS)-induced acute colitis in rats. Besides two control…
read more here.
Keywords:
self microemulsifying;
olmesartan medoxomil;
drug delivery;
microemulsifying drug ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Brazilian Journal of Medical and Biological Research"
DOI: 10.1590/1414-431x2023e12665
Abstract: There are few studies addressing duodenal inflammation. This study was designed to investigate the effects of a recently developed biotechnological product, a nano-formulation of olmesartan medoxomil (OM) - olmesartan medoxomil zeinmersomes (OMZ) - for the…
read more here.
Keywords:
induced duodenitis;
duodenitis;
olmesartan medoxomil;
indomethacin induced ... See more keywords